Analytical Data
-
基因名
TRAPPC2
- Application
-
别名
MIP-2A; SEDL; SEDT; TRS20; ZNF547L; Sedlin; Spondyloepiphyseal Dysplasia,Late
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P0DI81
-
表达区间
Met1~Ser140
-
分子量
18kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TRAPPC2 (Trafficking Protein Particle Complex 2) is a critical component of the TRAPP (Transport Protein Particle) complex, which plays a vital role in the regulation of intracellular trafficking and endosomal function. Mutations in the TRAPPC2 gene are linked to X-linked intellectual disability, emphasizing its significance in neuronal development and function. The study of TRAPPC2 recombinant protein is pivotal for understanding its structural and functional properties, as well as its interactions with other proteins within the TRAPP complex. By producing and characterizing TRAPPC2 as a recombinant protein, researchers can gain insights into its mechanisms of action, analyze how mutations affect protein function, and explore potential therapeutic avenues for TRAPPC2-related disorders. These investigations are essential for elucidating the underlying molecular pathways that contribute to intellectual disabilities and other neurodevelopmental conditions, paving the way for the development of targeted interventions. As our understanding of TRAPPC2 continues to grow, it holds promise for advancing the field of molecular neuroscience and for informing the creation of novel treatment strategies for affected individuals.
